Back
 OALibJ  Vol.1 No.8 , November 2014
Relation between Human Chorionic Gonadotropin and Thyroid Hormones in Preeclampsia
Abstract: Aim: Alterations in thyroid function with a simultaneous increase of hCG in some pregnancy diseases have been reported. However, the relationship between thyroid hormones and hCG during preeclampsia is not yet evaluated. In this study we determined serum levels of hCG, TSH, free T3 (fT3) and free T4 (fT4) in normal pregnant woman and in patients with preeclampsia and evaluated the correlation between these hormones. Methods: Blood samples were taken from 20 healthy pregnant women as control and from 20 patients with severe preeclampsia. Total hCG was measured by enzyme immunoassays. Serum concentrations of TSH, fT3 and fT4 were determined by chemiluminiescence method. Result: The average values of hCG were higher in the group with preeclampsia, but no statistically significant differences in relation to control group were observed. Likewise, no differences in serum concentrations of TSH, fT3 and fT4 between the control group and the group with preeclampsia were observed. Additionally, no correlation was observed between TSH, T3 and T4 with hCG. Conclusion: No correlation was observed between hCG and thyroid hormones. The different forms of hCG present in normal pregnancy and during preeclampsia could have different ways of stimulating the TSH receptor, which may be reflected in thyroid function.
Cite this paper: Camejo, M. and Casart, Y. (2014) Relation between Human Chorionic Gonadotropin and Thyroid Hormones in Preeclampsia. Open Access Library Journal, 1, 1-6. doi: 10.4236/oalib.1100652.
References

[1]   Kumar, A., Ghosh, B.K. and Murthy, N.S. (2005) Maternal Thyroid Hormonal Status in Preeclampsia. Indian Journal of Medical Sciences, 59, 57-63.
http://dx.doi.org/10.4103/0019-5359.13904

[2]   Kurioka, H., Takahashi, K. and Miyazaki, K. (2005) Maternal Thyroid Function during Pregnancy and Puerperal Period. Endocrine Journal, 52, 587-591.
http://dx.doi.org/10.1507/endocrj.52.587

[3]   Wasserstrum, N. and Anania, C.A. (1995) Perinatal Consequences of Maternal Hypothyroidism in Early Pregnancy and Inadequate Replacement. Clinical Endocrinology (Oxford), 42, 353-358.
http://dx.doi.org/10.1111/j.1365-2265.1995.tb02642.x

[4]   Lao, T.T., Chin, R.K.H., Swaminathan, R. and Lam, Y.M. (1990) Maternal Thyroid Hormones and Outcome of Pre-Eclamptic Pregnancies. British Journal of Obstetrics & Gynaecology, 97, 71-74.
http://dx.doi.org/10.1111/j.1471-0528.1990.tb01719.x

[5]   Vojvodic, L.J., Sulovic, V., Pervulov, M., Milacic, D. and Terzic, M. (1993) The Effect of Pre-Eclampsia on Thyroid Gland Function. Srpski Arhiv za Celokupno Lekarstvo, 121, 4-7.

[6]   Khaliq, F., Singhal, U., Arshad, Z. and Hossain, M.M. (1999) Thyroid Functions in Pre-Eclampsia and Its Correlation with Maternal Age, Parity, Severity of Blood Pressure and Serum Albumin. Indian Journal of Physiology and Pharmacology, 43, 193-198.

[7]   Larijani, B., Marsoosi, V., Aghakhani, S., Moradi, A. and Hashemipour, S. (2004) Thyroid Hormone Alteration in Pre-Eclamptic Women. Gynecological Endocrinology, 18, 97-100.
http://dx.doi.org/10.1080/09513590310001652973

[8]   Lao, T.T., Chin, R.K.H. and Swaminathan, R. (1988) Thyroid Function in Pre-Eclampsia. British Journal of Obstetrics & Gynaecology, 95, 880-883.
http://dx.doi.org/10.1111/j.1471-0528.1988.tb06573.x

[9]   Basbug, M., Aygen, E., Tayyar, M., Tutus, A., Kaya, E. and Öktem, Ö. (1999) Correlation between Maternal Thyroid Function Tests and Endothelin in Preeclampsia-Eclampsia. Obstetrics & Gynecology, 94, 551-555.
http://dx.doi.org/10.1016/S0029-7844(99)00332-4

[10]   Qublan, H.S., Al-Kaisi, I.J., Hindawi, I.M., Hiasat, M.S., Awamleh, I., Hamaideh, A.H., Abd-Alghani, I., Sou’ub, R.M., Abu-Jassar, H. and Al-Maitah, M. (2003) Severe Pre-Eclampsia and Maternal Thyroid Function. Journal of Obstetrics & Gynaecology, 23, 244-246.
http://dx.doi.org/10.1080/0144361031000098334

[11]   Neale, D.M., Cootauco, A.C. and Burrow, G. (2007) Thyroid Disease in Pregnancy. Clinics in Perinatology, 34, 543-557.
http://dx.doi.org/10.1016/j.clp.2007.10.003

[12]   Krajewski, D.A. and Burman, K.D. (2011) Thyroid Disorders in Pregnancy. Endocrinology and Metabolism Clinics of North America, 40, 739-763.
http://dx.doi.org/10.1016/j.ecl.2011.08.004

[13]   Negro, R. and Mestman, J.H. (2011) Thyroid Disease in Pregnancy. Best Practice & Research Clinical Endocrinology & Metabolism, 25, 927-943.
http://dx.doi.org/10.1016/j.beem.2011.07.010

[14]   Dafau, M. and Veldhuis, J. (1987) Pathophysiological Relationships between the Biological and Immunological Activities of Luteinizing Hormone. Baillière’s Clinical Endocrinology and Metabolism, 1, 153-176.
http://dx.doi.org/10.1016/S0950-351X(87)80057-5

[15]   Jaakkola, T., Ding, Y.Q., Kellokumpu-Lehtinen, P., Valavaara, R., Martikainn, H., Tapanaimen, J., et al. (1990) The Ratios of Serum Bioactive/Immunoactive Luteinizing Hormone and Follicle Stimulating Hormone in Various Clinical Conditions with Increased and Decreased Gonadotropin Secretion: Reevaluation by Highly Sensitive Immunometric Assays. The Journal of Clinical Endocrinology & Metabolism, 70, 1496-1505.
http://dx.doi.org/10.1210/jcem-70-6-1496

[16]   Hsu, C.D., Chan, D.W., Iriye, B., Johnson, T.R.B., Hong, S.F. and Repke, J.T. (1994) Elevated Serum Human Chorionic Gonadotropin as Evidence of Secretory Response in Severe Preeclampsia. American Journal of Obstetrics & Gynecology, 170, 1135-1138.
http://dx.doi.org/10.1016/S0002-9378(94)70108-3

[17]   Ashour, A.M., Lieberman, E.S., Haug, L.E. and Repke, J.T. (1997) The Values of Elevated Second-Trimester Beta-Human Chorionic Gonadotropin in Predicting Development of Preeclampsia. American Journal of Obstetrics & Gynecology, 176, 438-442.
http://dx.doi.org/10.1016/S0002-9378(97)70512-X

[18]   Merviel, P., Müller, F., Guibourdenche, J., Berkane, N., Gaudet, R., Bréat, G. and Uzan, S. (2001) Correlations between Serum Assays of Human Chorionic Gonadotropin (hCG) and Human Placental Lactogen (hLP) and Pre-Eclampsia or Intrauterine Growth Restriction (IUGR) among Nuliparas Younger than 38 Years. European Journal of Obstetrics & Gynecology and Reproductive Biology, 95, 59-67.
http://dx.doi.org/10.1016/S0301-2115(00)00370-5

[19]   Barros, J.S., Baptista, M.G. and Bairos, V.A. (2002) Human Chorionic Gonadotropin in Human Placentas from Normal and Preeclamptic Pregnancies. Archives of Gynecology and Obstetrics, 266, 67-71.
http://dx.doi.org/10.1007/s004040100181

[20]   Bartha, J.L., Romero-Carmona, R., Escobar-Llombar, M., Paloma-Castro, O. and Comino-Delgado, R. (2003) Human Chorionic Gonadotropin and Vascular Endothelial Growth Factor in Normal and Complicated Pregnancies. Obstetrics & Gynecology, 102, 995-999.
http://dx.doi.org/10.1016/S0029-7844(03)00808-1

[21]   Kato, K., Mostafa, M.H., Mann, K., Schindler, A.E. and Hoermann, R. (2004) The Human Chorionic Gonadotropin Molecule from Patients with Trophoblastic Diseases Has High Thyrotropic Activity but Is Less Active in the Ovary. Gynecological Endocrinology, 18, 269-277.
http://dx.doi.org/10.1080/09513590410001667247

[22]   Walkington, L., Webster, J., Hancock, B.W., Everard, J. and Coleman, R.E. (2011) Hyperthyroidism and Human Chorionic Gonadotropin Production in Gestational Trophoblastic Disease. British Journal of Cancer, 104, 1665-1669.
http://dx.doi.org/10.1038/bjc.2011.139

[23]   Yoshimura, M., Pekary, A.E., Pang, X.P., Berg, L., Goodwin, T.M. and Hershman, J.M. (1994) Thyrotropic Activity of Basic Isoelectric Forms of Human Chorionic Gonadotropin Extracted from Hydatidiform Mole Tissues. Journal of Clinical Endocrinology & Metabolism, 78, 862-866.

[24]   Goodwin, T.M., Montoro, M., Mestman, J.H., Pekary, A.E. and Hershman, J.M. (1992) The Role of Chorionic Gonadotropin in Transient Hyperthyroidism of Hyperemesis Gravidarum. Journal of Clinical Endocrinology & Metabolism, 75, 1333-1337.

[25]   Hershman, J.M. (2004) Physioloical and Pathological Aspect of the Effect of Human Chorionic Gonadotropin on the Thyroid. Best Practice & Research Clinical Endocrinology & Metabolism, 18, 249-265.
http://dx.doi.org/10.1016/j.beem.2004.03.010

[26]   Verberg, M.F.G., Gillott, D.J., Al-Fardan, N. and Grudzinskas, J.G. (2005) Hyperemesis Gravidarum, a Literature Review. Human Reproduction Update, 11, 527-539.
http://dx.doi.org/10.1093/humupd/dmi021

[27]   Wier, F. and Farley, C. (2006) Clinical Controversies in Screening Women for Thyroid Disorders during Pregnancy. Journal of Midwifery Women’s Health, 51, 152-158.
http://dx.doi.org/10.1016/j.jmwh.2005.11.007

[28]   Semlitsch, G., Buchinger, W., Reiterer, E., Binter, G. and Rainer, F. (2000) Measurement of Free Triiodothyronine (FT3) Using an Electrochemiluminescence Immunoassay in Patients with Autoantibodies to Triiodothyronine. Acta Medica Austriaca, 27, 54-55.

[29]   Sonan, M., Hiraoka, K., Yamada, E., Watanabe, S. and Kobayaski, M. (2001) Fundamental and Clinical Evaluation of TSH and Thyroid Hormone Measurement by Electrochemiluminescence Immunoassay System Modular Analytics (EE). Jpn J Med Pharm Sci., 46, 759-771.

[30]   Casart, Y.C., Camejo, M.I., Proverbio, F. and Febres, F. (2001) Bioactivity of Serum hCG in Preeclampsia. Obstetrics & Gynecology, 98, 463-465.
http://dx.doi.org/10.1016/S0029-7844(01)01463-6

[31]   Huang, S.C., Hwang, J.L., Hsieh, C.Y., Chen, R.J. and Ouyang, P.C. (1989) Human Chorionic Gonadotropin and Its Subunits in Pre-Eclampsia. Taiwan Yi Xue Hui Za Zhi, 88, 132-136.

[32]   Wenstrom, K.D., Owen, J., Boots, L.R. and DuBard, M.B. (1994) Elevated Second-Trimester Human Chorionic Gonadotropin Levels in Association with Poor Pregnancy Outcome. American Journal of Obstetrics & Gynecology, 171, 1038-1041.
http://dx.doi.org/10.1016/0002-9378(94)90030-2

[33]   Cole, L.A. (2009) New Discoveries on the Biology and Detection of Human Chorionic Gonadotropin. Reproductive Biology and Endocrinology, 26, 7-8.

[34]   Hoermann, R., Keutmann, H.T. and Amir, S.M. (1991) Carbohydrate Modifications Transform Human Chorionic Gonadotropin into a Potent Stimulator of Adenosine 3’,5’-Monophosphate and Growth Responses in FRTL-5 Thyroid Cells. Endocrinology, 128, 1129-1135.
http://dx.doi.org/10.1210/endo-128-2-1129

[35]   Pekary, A.E., Jackson, I.M.D., Goodwin, T.M., Pang, X.P., Hein, M.D. and Hershman, J.M. (1993) Increased in Vitro Thyrotropic Activity of Partially Sialated Human Chorionic Gonadotropin Extracted from Hydatidiform Moles of Patients with Hyperthyroidism. Journal of Clinical Endocrinology & Metabolism, 76, 70-74.

[36]   Yoshimura, M., Hershman, J.M., Pang, X.P., Berg, L. and Pekary, A.E. (1993) Activation of the Thyrotropin (TSH) Receptor by Human Chorionic Gonadotropin and Luteinizing Hormone in Chinese Hamster Ovary Cells Expressing Functional Human TSH Receptors. Journal of Clinical Endocrinology & Metabolism, 77, 1009-1013.

[37]   Hoermann, R., Kubota, K. and Amir, S.M. (1993) Role of Subunit Sialic Acid in Hepatic Binding, Plasma Survival Rate, and in Vivo Thyrotropic Activity of Human Chorionic Gonadotropin. Thyroid, 3, 41-47.
http://dx.doi.org/10.1089/thy.1993.3.41

[38]   Glinoer, D. (1997) The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology. Endocrine Reviews, 18, 404-433.
http://dx.doi.org/10.1210/edrv.18.3.0300

[39]   Cole, L.A. (2012) hCG, Five Independent Molecules. Clinica Chimica Acta, 413, 48-65.
http://dx.doi.org/10.1016/j.cca.2011.09.037

 
 
Top